Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

ClinicalTrials.gov ID: NCT07076199

Public ClinicalTrials.gov record NCT07076199. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 2:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study compares insulin icodec, an insulin taken once a week to insulin glargine, an insulin taken once a day. The study medicine will be investigated in participants with type 1 diabetes. The study will look at how well insulin icodec taken weekly controls blood sugar compared to insulin glargine taken daily. The study will last for about 8.5 months.

Study identification

NCT ID
NCT07076199
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
877 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 11, 2025 (Actual)
Primary completion
Jan 25, 2027 (Estimated)
Completion
Mar 1, 2027 (Estimated)
Last update posted
Sep 25, 2026

2025 – 2027

United States locations

U.S. sites
103
U.S. states
31
U.S. cities
88
Facility City State ZIP Site status
Cullman Clinical Trials Cullman Alabama 35055 —
John Muir Health Concord California 94520 —
Headlands Research California, LLC Escondido California 92025 —
Clinical Res of Central Ca Fresno California 93704 —
Providence Medical Foundation Fullerton California 92835 —
Scripps Whittier Diabetes Inst La Jolla California 92037 —
Loma Linda University Faculty Medical Clinics Loma Linda California 92354 —
Pacific Clinical Studies Los Alamitos California 90720 —
Los Angeles Institute for Metabolic Research Los Angeles California 90015 —
Pasadena Clinical Trials Pasadena California 91101 —
WestenU Health Pomona California 91766 —
Alliance Clinical Network San Diego California 92120 —
Mills Health Center San Mateo California 94401 —
Center for Endocrine DM and Metabolic Disorders Santa Clarita California 91321 —
University Clin Investigators Tustin California 92780 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
Denver Endocrinology Diabetes and Thyroid Center Englewood Colorado 80113 —
Optumcare Clinical Trials,LLC-Golden Golden Colorado 80401 —
Northeast Research Institute Fleming Island Florida 32003 —
Encore Medical Research LLC Hollywood Florida 33024 —
Northeast Research Institute Jacksonville Florida 32204 —
Life Spring Research Foundation LLC Miami Florida 33130 —
Suncoast Clinical Research, Inc. New Port Richey Florida 34652 —
West Orange Endocrinology Ocoee Florida 34761 —
Suncoast Clinical Research, Inc. Palm Harbor Florida 34684 —
Center for Diab,Obes & Metab Pembroke Pines Florida 33024 —
SRA Trials-Broward Pembroke Pines Florida 33024 —
Hanson Clinical Research Center Port Charlotte Florida 33952 —
Latin Clinical Trial Ctr Tamarac Florida 33321 —
Bayside Clinical Research Tampa Florida 33607 —
Metabolic Research Institute Inc West Palm Beach Florida 33401 —
Atlanta Diabetes Associates Atlanta Georgia 30318 —
Centricity Research Columbus Columbus Georgia 31904 —
Physicians Research Assoc. LLC Lawrenceville Georgia 30046 —
Endocrine Research Solutions, Inc Roswell Georgia 30076 —
Rocky Mt Clin Res, LLC Idaho Falls Idaho 83404-7596 —
Northwestern University Chicago Illinois 60611 —
University Of Chicago Chicago Illinois 60637-1447 —
Endeavor Health Skokie Illinois 60077 —
Indiana Uni School of Med-Ped Indianapolis Indiana 46202-5209 —
Iowa Diabetes Research West Des Moines Iowa 50266 —
Cotton O'Neil Diabetes & Endocrinology Topeka Kansas 66606 —
Robley Rex VA Medical Center Louisville Kentucky 40206 —
MedStar Health Research Institute Olney Maryland 20832 —
Brigham & Women's Hospital Boston Massachusetts 02115-5804 —
Profound Research LLC Clarkston Michigan 48346 —
Profound Research LLC Farmington Hills Michigan 48334 —
Elite Clinical Research Center Flint Michigan 48532 —
International Diabetes Center Minneapolis Minnesota 55416 —
Mayo Clinic Rochester Minnesota 55905 —
Saint Louis University St Louis Missouri 63103 —
Washington University St Louis Missouri 63110 —
QCR Network Omaha Nebraska 68114 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
Palm Research Center Inc. Las Vegas Nevada 89148 —
Albuquerque Clinical Trials Inc. Albuquerque New Mexico 87102 —
AMC Community Endocrinology Albany New York 12203 —
NYC Research, Inc. New York New York 10016 —
NYU Langone Orthopedic Center New York New York 10017 —
University at Buffalo Williamsville New York 14221 —
Physicians East Endocrinology Greenville North Carolina 27834 —
Centricity Rsrch MHCity Multi Morehead City North Carolina 28557 —
Centricity Res New Bern Multispeciality New Bern North Carolina 28562 —
Accellacare of Raleigh Raleigh North Carolina 27609 —
Accellacare Wilmington Wilmington North Carolina 28401 —
Diab & Endo Assoc of Stark Co Canton Ohio 44718 —
Cleveland Clinic_Cleveland Cleveland Ohio 44195 —
The Ohio State University Medical Center Columbus Ohio 43203 —
Alliance for Multispecialty Research Norman Oklahoma 73069 —
Lynn Institute of Norman Norman Oklahoma 73069 —
Lynn Institute - East OKC Oklahoma City Oklahoma 73111 —
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 —
Prisma Health Endo Spc Thy Ctr Greenville South Carolina 29605 —
Holston Medical Group_Bristol Bristol Tennessee 37620 —
University Diabetes & Endocrine Consultants Chattanooga Tennessee 37411 —
MidState Endocrine Associates Nashville Tennessee 37203 —
Vanderbilt Medical Center_Nashville Nashville Tennessee 37212 —
Amarillo Medical Specialists Amarillo Texas 79124 —
Texas Diab Endo ATX N Mopac EXPR Austin Texas 78731 —
Texas Diabetes & Endocrinology Austin Texas 78749 —
Alliance Clinical Network Dallas Texas 75203 —
Thyroid Endocrinology & Diabetes PA Dallas Texas 75208 —
Velocity Clinical Res-Dallas Dallas Texas 75230 —
North Texas Endocrine Center Dallas Texas 75231 —
Research Institute Of Dallas Dallas Texas 75231 —
Precision Endo - Revival Denton Texas 76210 —
Epic Medical Research DeSoto Texas 75115 —
Frontier Medical Ctr El Paso Texas 79935 —
N. Texas Diab & Endo - Prime Flower Mound Texas 75028 —
Diabetes and Thyroid Center of Fort Worth Fort Worth Texas 76132 —
Houston Endocrinology Center Houston Texas 77040 —
The Endocrine Center Houston Texas 77079 —
Amir Ali Hassan, MD, PA Houston Texas 77089 —
RGV Endocrine Center McAllen Texas 78503 —
Tekton Research McKinney Texas 75069 —
Be Well Clinical Studies Round Rock Texas 78681 —
Texas Diabetes & Endocrinology_Round Rock Round Rock Texas 78681 —
Northeast Clinical Research of San Antonio San Antonio Texas 78233 —
Valley Diab. & Endo Comp Ctr Weslaco Texas 78596 —
Rio Clinical Trials Ogden Utah 84404 —
UVM Endocrinology South Burlington Vermont 05403 —
Rainier Clin Res Ctr Inc Renton Washington 98057 —
Prevea Health Green Bay Wisconsin 54303 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07076199, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07076199 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →